T. Rowe Price Investment Management, Inc., a registered investment adviser, initiated a new position in Arcellx, Inc. Common Stock (NASDAQ:ACLX) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 10,560,425 shares of the Healthcare company, valued at approximately $688.5M as of the filing date.
Arcellx, Inc. Common Stock's stock currently trades at $113.83 with a market capitalization of $4.0B.